Anteris Technologies Global Corp. — Capital/Financing Update 2015

Dec 21, 2015

ASX ANNOUNCEMENT

==> picture [196 x 73] intentionally omitted <==

Notice under Section 708A(5)(e) of the Corporations Act

22 December 2015

On 18 December 2015, Admedus Limited ( Company ) issued 10,500,000 fully paid ordinary shares in the capital of the Company ( Shares ) to an institutional investor at a price of $0.66 per Share pursuant to the terms of a placement agreement (refer further to the Company's announcement dated 22 December 2015).

The Corporations Act 2001 (Cth) ( Act ) restricts the on-sale of securities issued without disclosure, unless the sale is exempt under the section 708 or 708A. By the Company giving this notice, a sale of the Shares will fall within the exemption in section 708A(5) of the Act.

The Company hereby notifies ASX under paragraph 708A(5)(e) of the Act that:

1. the Company issued the Shares without disclosure to investors under Part 6D.2 of the Act;

2. as at the date of this notice, the Company has complied with the provisions of Chapter 2M of the Act as they apply to the Company, and section 674 of the Act; and

3. as at the date of this notice, there is no information:

   • (a) that has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

   • (b) that investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

     • (i) the assets and liabilities, financial position and performance, profits and losses and prospect and prospects of the Company; or

     • (ii) the rights and liabilities attaching to the securities.

Yours faithfully

Stephen Mann Company Secretary Admedus Limited

==> picture [595 x 43] intentionally omitted <==